As noted by the latest advisory from the #surgeongeneral, there are cancer risks associated with any #alcohol use.

"We're not telling people not to drink; we're just promoting informed choice based on the most accurate, updated information about alcohol and cancer risk." Learn more. ⬇️

How are cutting-edge developments in cancer science paving the way for more inclusive clinical trials? Join a virtual AACR Patient Advocate Forum: Exploring a New Generation of Patient-Centric Cancer Clinical Trials, on January 21 at 1 pm ET to learn more: bit.ly/401TuwH #AACRForum

Bladder cancer ranks among the top 10 cancers worldwide, driven by aging, smoking, & demographic shifts. Prevention, early detection (e.g., urinary biomarkers), & awareness are vital to ease its growing burden on health systems. #BladderCancer #Oncologyc @oncoalert.bsky.social
rdcu.be/d49N9

Immunotherapy shows sex bias—men respond better; women face more severe AEs. Understanding sex hormones, chromosomes, and epigenetics in immunity could lead to tailored immuno-oncology strategies. #Cancer #Immunotherapy #Oncology @oncoalert.bsky.social
rdcu.be/d49Mq

It is a hard time of year for many. Check in with one another. 8 min for a friend? Love this #CanSky #PallSky #PallOnc youtube.com/shorts/2lH6x...

🚨It’s Friday & we have another FDA approval 👉🏼FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors onclive.com/view/fda-appro… via https://www.onclive.com/view/fda-approves-subcutaneous-nivolumab-in-advanced-or-metastatic-solid-tumors

Everyone with #EarlyOnsetCRC wants to know why they were diagnosed with #colorectalcancer..

This month's #CRCTrialsChat #VideoShorts on the @CancerGrand #PROSPECT project explores this question

Let's hear from the PIs, Dr. @AndyChanMD & Dr. @yincaoScD
#CRCSM

As an oncologist, I get constant reminders that holidays are joyful & meaningful milestones, but not every yr & not for everyone. If you are with #grief, I hope this will remind you that you belong to something vast & are not alone.

#MedSky #OncSky #LongCovid

www.nytimes.com/2024/12/20/s...

🩸🧬Liquid Biopsy & MRD: ctDNA-based MRD detection in solid tumors can predict relapse months before imaging. A new era of post-adjuvant therapies may eliminate MRD. #Oncology #LiquidBiopsy #CancerResearch #PrecisionMedicine
@oncoalert.bsky.social
@christianrolfo.bsky.social
rdcu.be/d4gVU

📢 FDA grants accelerated approval to encorafenib + cetuximab + mFOLFOX6 for treatment-naïve mCRC with BRAF V600E mutation. BREAKWATER trial shows 61% ORR!
Median DoR: 13.9 months. Most common toxicities: neuropathy, nausea, fatigue.
@oncoalert.bsky.social @fda.gov
@oncbrothers.bsky.social

Instead of listing my publications, as the year draws to an end, I want to shine the spotlight on the commonplace assumption that productivity must always increase. Good research is disruptive and thinking time is central to high quality scholarship and necessary for disruptive research.

Thanks to Dr. Mark Lewis for posting about his colonoscopy on X.
Adding screenshots of his tweets here.
#CRCSM

Welcome @ascocancer.bsky.social to 🦋! @tmprowell.bsky.social @mcuban.bsky.social @lynnschuchter.bsky.social @lisagreaves.bsky.social @oncodaily.bsky.social @crisbergerot.bsky.social @acscan.bsky.social @jrgralow.bsky.social @drkomanduri.bsky.social @beverlymoy.bsky.social @pallonccop.bsky.social

The authors suggests ways to show gratitude meaningfully and create a culture where your employees feel their work is seen, supported, and valued #medsky #oncsky #oncnsgsky hbr.org/2024/11/when...

A new trial we’re funding uses an innovative ‘pill-on-a-thread’ test to screen people with heartburn for Barrett’s oesophagus, a condition that can lead to oesophageal cancer – and it's easier and cheaper than endoscopies. Read more: cruk.ink/best4